000165394 001__ 165394
000165394 005__ 20260107201858.0
000165394 0247_ $$2doi$$a10.3390/jcm15010101
000165394 0248_ $$2sideral$$a147056
000165394 037__ $$aART-2025-147056
000165394 041__ $$aeng
000165394 100__ $$aIoakeim-Sokoufa, Ignatios$$uUniversidad de Zaragoza
000165394 245__ $$aMultimorbidity in Focus: Emerging Patterns, Medication Appropriateness and Clinical Innovation
000165394 260__ $$c2025
000165394 5060_ $$aAccess copy available to the general public$$fUnrestricted
000165394 5203_ $$aChronic conditions and multimorbidity are significantly altering the landscape of modern clinical care. When we launched this Special Issue, our goal was to compile research that sheds light on these challenges from various perspectives, including clinical, epidemiological, methodological and patient-centred. This Special Issue provides insights into disease trajectories, medication safety, vulnerable populations and emerging tools to understand and address multimorbidity, such as artificial intelligence (AI). We are grateful to all the contributing authors, the reviewers who enhanced the manuscripts and the editorial team of the Journal of Clinical Medicine for their support in this endeavour. Recent advancements in medicine and technology have improved the survival and management of chronic conditions. Multimorbidity has now become a common clinical concern among adults of all ages, from the young population to people over 100 [1,2,3,4]. This epidemiological shift poses significant challenges for healthcare providers and national health and social care systems, where clinical guidelines mainly focus on single diseases, failing to consider a person-centred approach in the management of people with multiple chronic conditions. The contributions in this Special Issue collectively underline that multimorbidity is not a static construct but a dynamic process that evolves across life stages, involves clinical and pharmacological interactions, and requires a re-engineering of current models of care
000165394 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000165394 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000165394 700__ $$aAza-Pascual-Salcedo, Mercedes
000165394 700__ $$aCoelho, Helena
000165394 700__ $$aVicente-Romero, Jorge
000165394 7102_ $$11012$$2315$$aUniversidad de Zaragoza$$bDpto. Farmac.Fisiol.y Med.L.F.$$cÁrea Farmacología
000165394 773__ $$g15, 1 (2025), 101 [6 pp.]$$pJ. clin.med.$$tJournal of Clinical Medicine$$x2077-0383
000165394 8564_ $$s188672$$uhttps://zaguan.unizar.es/record/165394/files/texto_completo.pdf$$yVersión publicada
000165394 8564_ $$s2537754$$uhttps://zaguan.unizar.es/record/165394/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000165394 909CO $$ooai:zaguan.unizar.es:165394$$particulos$$pdriver
000165394 951__ $$a2026-01-07-18:53:46
000165394 980__ $$aARTICLE